Raloxifene, an oestrogen-receptor modulator, prevents decreased constitutive nitric oxide and vasoconstriction in ovariectomized rats

European Journal of Pharmacology

Volumn 410, Issue 1, 2000, Pages 101-104

  Pávó, Imre ^a   László, Ferenc ^b   Morschl, Éva ^b   Nemcsik, János ^b   Berkó, Anikó ^c   Cox, David A ^d   László, Ferenc A ^c  

^a Eli Lilly Area Medical Center   (Austria)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

Blood pressure; Enzyme regulation; Nitric oxide (NO); Oestrogen; Oestrogen receptor modulator; Vasopressin

Indexed keywords

ARGIPRESSIN; CALCIUM; CITRULLINE; ESTRADIOL; ESTROGEN RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENTOLAMINE; RALOXIFENE; VASOPRESSIN;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; ESTROGEN THERAPY; FEMALE; HORMONE ACTION; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; VASOCONSTRICTION;

ANIMALS; BLOOD PRESSURE; CALCIUM; CATECHOLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS; FEMALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; OVARIECTOMY; OVARY; RALOXIFENE; RATS; RATS, WISTAR; SELECTIVE ESTROGEN RECEPTOR MODULATORS; VASOCONSTRICTION; VASOPRESSINS;

EID: 0034694773     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00865-7     Document Type: Article

References (14)

1. Gonadal hormone substitutes: Effects on cardiovascular system
2. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric oxide synthase in vitro and in vivo
3. Effects of 17beta-estradiol on the baroreflex control of sympathetic activity in conscious ovariectomized rats
4. Constitutive nitric oxide modulates the injurious actions of vasopressin on rat intestinal microcirculation in acute endotoxaemia
5. Endogenous nitric oxide in the maintenance of rat microvascular integrity against widespread plasma leakage following abdominal laparotomy
6. Pharmacology and clinical perspectives of vasopressin antagonists
7. Stimulus for vasopressin release during elective intra-abdominal operations
8. Molecular mechanisms and therapeutic strategies related to nitric oxide
9. Estrogen-mediated up-regulation of the Ca-dependent constitutive nitric oxide synthase in the rat aorta and heart
10. Interactions of pro-inflammatory and vasoactive mediators with nitric oxide in the regulation of rat vascular permeability during laparotomy
11. Estrogen and selective estrogen receptor modulator LY117018 enhance release of nitric oxide in rat aorta
12. Widespread tissue distribution, species distribution and changes in activity of Ca(2+)-dependent and Ca(2+)-independent nitric oxide synthases
13. Induction of calcium-dependent nitric oxide synthases by sex hormones
14. Coronary and uterine vascular responses to raloxifene in the sheep